Company / Return on Equity (ROE)
Medtronic Return on Equity (ROE) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
7.8%
FY2025
5-year range
7.0% / 9.3%
FY2021-FY2025
Trend
-15.6%
vs FY2024
Sector context
#61 of 148
Health Care
What the data says
At 7.8%, Medtronic's return on equity (roe) ranks #61 of 148 in the Health Care sector. Return on Equity (ROE) has fluctuated over the past 9 years, ranging from 6.2% in FY2017 to 9.6% in FY2019.
Based on SEC 10-K filings.
7.8% in FY2025 with a 5-year CAGR of +0.7%.
Improved from 7.0% to 7.8% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -1.3pp
- 5-Year Change
- +0.7pp
- 10-Year Change
- -
Sector benchmark
#61 of 148 in Health CareTop 41% of 148This company 7.8% Sector average -3.2%
▼
+347.9% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 15.6% year-over-year.
- Currently 11.0pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2019.
- Lowest return on equity (roe) in the period was in FY2017.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | 7.8% | -15.6% |
| FY2024 | 9.3% | +32.6% |
| FY2023 | 7.0% | -23.2% |
| FY2022 | 9.1% | +1.2% |
| FY2021 | 9.0% | +26.6% |
| FY2020 | 7.1% | -25.6% |
| FY2019 | 9.6% | +4.7% |
| FY2018 | 9.1% | +47.7% |
| FY2017 | 6.2% | -20.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026